Successful Completion of the MDIP Lab Grow Module: A Milestone for Pharmatech AI

Successful Completion of the MDIP Lab Grow Module: A Milestone for Pharmatech AI

January 15th, 2025 – We are thrilled to announce a pivotal achievement in Pharmatech AI’s history: The construction of our state-of-the-art MDIP Lab Grow Module was completed on schedule in January 2025. This 200 m² cutting-edge research facility combines vertical cannabis cultivation with AI-driven analytics, marking a major leap forward in our mission to revolutionize...

Unlocking Drug Discovery: The AI-Driven Vision of Pharmatech AI’s Whitepaper

Unlocking Drug Discovery: The AI-Driven Vision of Pharmatech AI’s Whitepaper

At Pharmatech AI, we believe that true innovation thrives on openness. While our business plan outlines our commercial strategy, our 39-page whitepaper has unexpectedly become our flagship document, not for its length, but for its unprecedented transparency and scientific rigor. Here’s why it’s become a game-changer for investors, researchers, and the pharmaceutical industry alike. 1....

Construction of our MDIP Lab Grow has begun

Construction of our MDIP Lab Grow has begun

Our multi-million-euro research center is poised to redefine precision cannabinoid production and cannabis cultivation through its state-of-the-art hybrid cultivation-research facility. By integrating real-time research data directly into cultivation protocols, we can test countless molecular combinations while simultaneously growing new cultivars to validate theoretical models in practice. This groundbreaking investment delivers a globally unique cultivation module...

Location Strategy: Why Mecklenburg-Vorpommern in Germany?

Location Strategy: Why Mecklenburg-Vorpommern in Germany?

The decision to establish our headquarters here followed an extensive Europe-wide search across 23 potential locations. We evaluated numerous factors, each carrying varying degrees of influence on our final choice. Mecklenburg-Vorpommern ultimately stood out due to its unique combination of: Infrastructure Direct connection to the 110 kV power grid Fiber-optic internet with 10 Gbit/s bandwidth...

Why AI-Driven Cannabinoid Research is an Untapped Billion-Dollar Potential

Market Research Pharmatech AI

To align our business model for long-term success, we conducted an in-depth market analysis early on, with results that confirmed and accelerated our strategic direction. A five-member research team conducted over 200 in-depth interviews with stakeholders, from pharmacists in Munich to pain specialists in Boston. The findings were clear: 1. High Dissatisfaction with Existing Therapies...

The Birth of Pharmatech AI: How It All Began

The Birth of Pharmatech AI: How It All Began

In early 2024, we laid the foundation for what is now one of Europe’s most innovative pharmaceutical research companies. The founding of Pharmatech AI was not a spontaneous venture but the result of months of strategic planning. Our team of seasoned scientists, AI experts, and pharmaceutical specialists shared a common vision: to revolutionize drug discovery...

Welcome to Pharmatech AI – Our Website is Now Live!

Welcome to Pharmatech AI – Our Website is Now Live!

We’re thrilled to announce that PharmaTech-AI is officially live! Our new website marks the beginning of an exciting journey as we introduce our cutting-edge AI-MDIP for the pharmaceutical industry and work together to shape the future of healthcare. Here, you’ll find insights into our technology, ongoing projects, and opportunities for collaboration. What can you expect...